1. Home
  2. LEDS vs VTGN Comparison

LEDS vs VTGN Comparison

Compare LEDS & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

HOLD

Current Price

$2.15

Market Cap

13.5M

Sector

Technology

ML Signal

HOLD

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.24

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEDS
VTGN
Founded
2005
1998
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
10.8M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
LEDS
VTGN
Price
$2.15
$0.24
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$0.90
AVG Volume (30 Days)
26.2K
603.0K
Earning Date
04-14-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
53.12
N/A
EPS
0.02
N/A
Revenue
$43,009,000.00
N/A
Revenue This Year
N/A
$124.49
Revenue Next Year
N/A
$353.99
P/E Ratio
$107.50
N/A
Revenue Growth
729.81
N/A
52 Week Low
$1.01
$0.20
52 Week High
$3.62
$5.14

Technical Indicators

Market Signals
Indicator
LEDS
VTGN
Relative Strength Index (RSI) 52.94 41.03
Support Level $1.75 $0.23
Resistance Level $2.17 $0.32
Average True Range (ATR) 0.15 0.01
MACD 0.01 0.00
Stochastic Oscillator 75.00 28.46

Price Performance

Historical Comparison
LEDS
VTGN

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: